Literature DB >> 16815761

A simple and rapid liquid chromatography method for simultaneous determination of zidovudine and nevirapine in plasma.

Geetha Ramachandran1, A K Hemanthkumar, V Kumaraswami, Soumya Swaminathan.   

Abstract

We describe a simple, fast, isocratic, reversed-phase high performance liquid chromatographic method for simultaneous determination of plasma zidovudine and nevirapine with UV detection at 260 nm. The method involves liquid-liquid extraction with ethyl acetate and using 3-isobutyl 1-methyl xanthine as internal standard. The system requires a C(18) column (150 mm x 4.6 mm I.D.) and a mobile phase composed of potassium dihydrogen phosphate (15 mM; pH 7.5) and acetonitrile in the ratio of 80:20 (v/v). The assay was linear from 0.025 to 10.0 microg/ml for zidovudine and 0.05 to 10.0 microg/ml for nevirapine. The intra- and inter-day variations were less than 10% for both the drugs. The method was specific and sensitive enough to allow quantification of zidovudine and nevirapine in concentrations observed clinically. The average recoveries of zidovudine and nevirapine from plasma were 95 and 94%, respectively. The method was applied to a pharmacokinetic study in HIV-infected patients who were receiving antiretroviral treatment with zidovudine and nevirapine containing regimens. The method spans the blood concentration range of clinical interest. Due to its simplicity, the assay can be used for pharmacokinetic studies and therapeutic drug monitoring in patients taking a combination treatment of zidovudine and nevirapine.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16815761     DOI: 10.1016/j.jchromb.2006.06.014

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  6 in total

1.  Study of ABCB1 polymorphism (C3435T) in HIV-1-infected individuals from South India.

Authors:  Siddharth Bakshi; Geetha Ramachandran; Karunaianandham Ramesh; Agibothu K Hemanthkumar; Suresh Anitha; Chandrasekaran Padmapriyadarsini; Gopalan Narendran; Pradeep A Menon; Sikhamani Rajasekaran; Soumya Swaminathan
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

2.  Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction.

Authors:  Mitzi Glover; Valeria Y Hebert; Krystle Nichols; Stephen Y Xue; Taylor M Thibeaux; James A Zavecz; Tammy R Dugas
Journal:  Antiviral Res       Date:  2014-09-27       Impact factor: 5.970

3.  Thermal stability and decomposition kinetic studies of acyclovir and zidovudine drug compounds.

Authors:  Mojtaba Shamsipur; Seied Mahdi Pourmortazavi; Ali Akbar Miran Beigi; Rouhollah Heydari; Mina Khatibi
Journal:  AAPS PharmSciTech       Date:  2013-01-09       Impact factor: 3.246

4.  Factors influencing plasma nevirapine levels: a study in HIV-infected children on generic antiretroviral treatment in India.

Authors:  Soumya Swaminathan; Geetha Ramachandran; Hemanth Kumar Agibothu Kupparam; Vasantha Mahalingam; Lakshmi Soundararajan; Bhavani Perumal Kannabiran; Poorana Ganga Devi Navaneethapandian; Ira Shah; Ramesh Karunaianandham; Rajasekaran Sikhamani
Journal:  J Antimicrob Chemother       Date:  2011-03-09       Impact factor: 5.790

5.  Sub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: Implications for therapeutic drug monitoring.

Authors:  Bindu Parachalil Gopalan; Kayur Mehta; Reena R D'souza; Niharika Rajnala; Hemanth Kumar A K; Geetha Ramachandran; Anita Shet
Journal:  PLoS One       Date:  2017-08-21       Impact factor: 3.240

6.  Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients.

Authors:  Geetha Ramachandran; A K Hemanth Kumar; C Ponnuraja; K Ramesh; Lakshmi Rajesh; C Chandrasekharan; Soumya Swaminathan
Journal:  Indian J Med Res       Date:  2013-12       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.